Our reports provide an independent, expert view supported by robust and innovative data interrogation and analysis.

Sort by:
Global Dermatology Drugs Market to 2024 – IL Signaling Inhibitors to Overtake TNF-a Inhibitors as Leading Commercial Drug Class with Dupixent and Cosentyx among Key Performers

Published: Dec-2018

Dermatological conditions, diseases of the skin, hair and nails, are one of the most common types of disorders worldwide,.....

$4995
More Info
Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 – Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market

Published: Dec-2018

Non-alcoholic steatohepatitis (NASH) is the severe form of non-alcoholic fatty liver disease (NAFLD), characterized by.....

$4995
More Info
Epilepsy Therapeutics in Asia-Pacific Markets to 2024 – Uptake of Novel Therapies and Rising Awareness is Expected to Drive the Market Growth

Published: Nov-2018

Epilepsy is a chronic disorder of the brain with substantial morbidity. There are more than 65 million people with epilepsy.....

$4995
More Info
Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 – Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

Published: Nov-2018

Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex.....

$4995
More Info
Chronic Respiratory Disease Drug Development Pipeline Review, 2018

Published: Nov-2018

This report provides an overview of the pipeline landscape for chronic respiratory diseases. It provides comprehensive.....

$3995
More Info
Transplant Complications Drug Development Pipeline Review, 2018

Published: Nov-2018

This report provides an overview of the pipeline landscape for transplant complications. It provides comprehensive information.....

$3995
More Info
Constrained Public Healthcare Budgets and the Pharmaceutical Industry - Featuring Expert Panel Views From Industry Survey, 2018

Published: Nov-2018

GBI Research’s latest report: “Constrained Public Healthcare Budgets and the Pharmaceutical Industry - Featuring.....

$2995
More Info
Hereditary Hematological Disorders Drug Development Pipeline Review, 2018

Published: Oct-2018

This report provides an overview of the pipeline landscape for hereditary hematological disorders. It provides comprehensive.....

$3995
More Info
Optic Nerve Disorders Drug Development Pipeline Review, 2018

Published: Oct-2018

This report provides an overview of the pipeline landscape for disorders of the optic nerve, the bundle of nerve fibers.....

$3995
More Info
Biobanking: Key Operational, Regulatory and Ethical Trends Within the R&D and Commercial Landscape

Published: Oct-2018

GBI Research’s latest report: “Biobanking: Key Operational, Regulatory and Ethical Trends Within the R&D.....

$2995
More Info
Sort by: